HOYA (HOCPY) AI Stock Analysis

• Market Cap: $49.58B
• Dividend Yield: 0.45%
• Average Volume (3M): 2.84K
• Price to Earnings (P/E): 36.3
• Beta (1Y): 0.84
• Revenue Growth: 9.69%
• EPS Growth: 9.99%
• Country: US
• Employees: 35,702
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 1.02
• Shares Outstanding: 343,122,620
• 10 Day Avg. Volume: 1,899
• 30 Day Avg. Volume: 2,844
• PEG Ratio: 2.28
• Price to Book (P/B): 6.06
• Price to Sales (P/S): 6.66
• P/FCF Ratio: 31.53
• Enterprise Value/Market Cap: 0.75
• Enterprise Value/Revenue: 0.04
• Enterprise Value/Gross Profit: 0.05
• Enterprise Value/Ebitda: 0.09
• 1Y Price Target: $165.00
• Price Target Upside: 13.53% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 78 Outperform
• Price Target: $165.00 ▲(13.53% Upside)

HOYA's strong financial performance and positive technical indicators are the primary drivers of its stock score. The company's robust financial health and positive market momentum outweigh the relatively high valuation and low dividend yield.

HOYA Business Overview & Revenue Model

Company Description

HOYA Corporation (HOCPY) is a global technology company headquartered in Tokyo, Japan, specializing in the development and manufacturing of optical products, medical devices, and electronic materials. The company operates in two main segments: the Life Care segment, which focuses on healthcare-related products such as intraocular lenses and healthcare services, and the Electronics segment, which produces high-performance photomasks used in semiconductor manufacturing and other electronic components. HOYA is renowned for its precision optics, including camera lenses and eyeglasses, and has a strong presence in both consumer and industrial markets.

How the Company Makes Money

HOYA generates revenue through multiple streams, primarily from its Life Care and Electronics segments. In the Life Care segment, significant revenue comes from the sale of intraocular lenses for cataract surgery and other ophthalmic products, as well as dental products and health-related services. The Electronics segment primarily earns revenue through the production of photomasks and other critical components used in semiconductor manufacturing, catering to the growing demand for advanced electronics. Additionally, HOYA has established partnerships with various healthcare institutions and technology companies, enhancing its market reach and driving sales growth. The company's diverse portfolio and strong R&D capabilities also contribute to its financial performance, enabling it to innovate and meet evolving market needs.

HOYA Financial Statement Overview

Summary

HOYA exhibits strong financial health with robust profitability, minimal leverage, and solid cash flow generation. The company's financial position is fortified by high equity levels and substantial cash reserves, positioning it well for sustained growth and resilience against economic challenges.

Income Statement

HOYA demonstrates strong profitability with robust gross profit and net profit margins across the years. The company has shown consistent revenue growth, achieving an impressive revenue growth rate from 2024 to 2025, indicating solid market demand and operational efficiency. The EBIT and EBITDA margins are also healthy, reflecting effective cost management. However, the growth rate between 2020 and 2021 was less pronounced, suggesting some variability in revenue expansion.

Balance Sheet

HOYA's balance sheet is notably strong, characterized by a high equity ratio indicating substantial shareholder funding compared to total assets. The debt-to-equity ratio is low, highlighting minimal leverage and reduced financial risk. Return on equity is strong, showcasing effective management in generating returns from shareholder investment. The company's substantial cash reserves further enhance financial stability.

Cash Flow

The cash flow statement reflects a positive trajectory, with consistent free cash flow generation supporting the company's growth initiatives. The operating cash flow to net income ratio is favorable, indicating efficient conversion of earnings into cash. Although the free cash flow growth rate varies across years, the overall trend is upward, suggesting prudent capital expenditure management. A minor point of concern is the fluctuation in investing cash flow, which could impact future profitability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	875.46B	885.82B	762.61B	734.10B	670.33B	558.26B
Gross Profit	688.65B	766.25B	421.69B	631.86B	567.28B	474.98B
EBITDA	428.77B	310.00B	285.70B	259.78B	243.96B	200.27B
Net Income	206.78B	202.10B	181.38B	168.64B	164.51B	125.45B
Balance Sheet
Total Assets	1.23T	1.23T	1.20T	1.03T	992.84B	853.29B
Cash, Cash Equivalents and Short-Term Investments	533.64B	538.53B	525.16B	426.27B	426.63B	338.79B
Total Debt	39.24B	37.28B	29.24B	24.58B	21.60B	20.75B
Total Liabilities	258.76B	262.65B	241.36B	213.72B	203.78B	180.88B
Stockholders Equity	976.83B	974.02B	967.76B	818.32B	803.85B	688.00B
Cash Flow
Free Cash Flow	192.85B	187.19B	181.73B	168.36B	161.18B	120.57B
Operating Cash Flow	242.94B	235.11B	222.80B	201.83B	190.06B	151.81B
Investing Cash Flow	-43.34B	-33.19B	-35.81B	-47.50B	-29.30B	-29.79B
Financing Cash Flow	-181.41B	-190.35B	-110.89B	-194.59B	-106.72B	-115.67B

HOYA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 145.33
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Positive. The current price of 145.33 is above the 20-day moving average (MA) of 142.79, above the 50-day MA of 136.38, and above the 200-day MA of 124.72, indicating a bullish trend. The MACD of 2.53 indicates Positive momentum. The RSI at 53.26 is Neutral, neither overbought nor oversold. The STOCH value of 53.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HOCPY.

HOYA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RMD	79 Outperform	$41.21B	29.70	25.86%	0.79%	9.84%	37.48%
HOCPY	78 Outperform	$49.58B	36.32	21.19%	0.45%	9.69%	9.99%
ISRG	78 Outperform	$160.63B	61.92	16.02%	―	20.77%	23.16%
WST	78 Outperform	$19.27B	40.13	17.72%	0.32%	2.88%	-5.50%
BDX	69 Neutral	$55.18B	34.62	6.26%	2.23%	7.86%	14.24%
HOLX	69 Neutral	$15.20B	28.47	11.38%	―	1.28%	-17.73%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%